The supplied filings tie this legal applicant to one product line: Vitrea Advanced Visualization. FDA records list Canon Medical Informatics, Inc. as applicant for K263648, received October 2, 2026 and decided October 29, 2026, with decision code SESE and decision description Substantially Equivalent. The device is named Vitrea Advanced Visualization, Version 7.16, under product code LLZ and regulation number 892.2050, with device name System, Image Processing, Radiological, device class 2 and medical specialty Radiology. The filing carries a Summary and a Special clearance type, and the third-party review flag is N. The FDA letter states the agency reviewed the section 510(k) premarket notification and determined the device substantially equivalent to legally marketed predicate devices. [1][4]

The applicant and the cleared device

The applicant name in the FDA record is Canon Medical Informatics, Inc., with a Minnetonka, MN address and contact listed as Jay Vaishnav. That address appears in a regulatory filing and is not treated here as a headquarters. The cleared device is Vitrea Advanced Visualization, Version 7.16, classified under product code LLZ with advisory committee Radiology. The record shows a decision date of October 29, 2026, roughly four weeks after the October 2, 2026 receipt date. [1]

The FDA clearance letter confirms the substantial-equivalence determination for the indications for use stated in the enclosure. The supplied excerpt does not reproduce those indications, so the specific clinical uses cleared in K263648 remain unknown from these sources. [4]

What Vitrea is documented to do

Canon Medical's product page describes Vitrea Advanced Visualization as full-powered solutions and workflows for 2D, 3D and 4D advanced visualization, with a multi-modality, vendor-agnostic approach that unites diagnostic imaging systems with advanced clinical applications. The page lists Cardiac Imaging, Vascular Imaging, Neuro Imaging and Oncology Imaging among the application areas. The global Canon Medical page similarly describes Vitrea software as a multi-modality vendor-agnostic advanced visualization system with applications across single-site to multi-site IT environments, and mentions in-suite 3D viewing, semi-automated measurements and Global Illumination rendering technology. [3][8]

A Canon Medical Systems USA page frames Vitrea Advanced Visualization as a suite of advanced CT clinical applications intended to help standardize and consolidate a radiology IT footprint, with clinical applications for 2D and 3D work. These are publisher descriptions of product scope, not independent performance evidence. [7]

Versioning, interoperability and release documentation

A DICOM Conformance Statement bearing document ID VLC-11218 A covers Vitrea Advanced Visualization 7.16 and lists patient, study, series, frame of reference, equipment, image, image plane and image pixel modules as ALWAYS present. The document carries a 2022 copyright line and an incomplete date field, so its exact issue date is unknown. [2]

Release notes for Vitrea Advanced Visualization 7.16.0.SU02, document VPMC-17248D with a 2024-07 publication date, record a fix under PI-28913 concerning renamed Algorithm Processing JIT tasks persisting after an upgrade. A separate GUDID record lists brand name Vitrea Advanced Visualization, version or model 7.16.0.SU04, primary DI 00850025268325, status In Commercial Distribution, with lot or batch and manufacturing date as production identifiers. The relationship between the 7.16 FDA submission and the SU02 and SU04 versions is not stated in the public information. [5][6]

How to read the filing record

The supplied collection contains one linked 510(k) record, and the decision counts show one SESE decision across that collection; the smaller record sample likewise contains that single SESE entry. These are counts of the supplied filings as of the snapshot, not measures of total company sales, total portfolio or safety performance. No recall records appear in the supplied sample. [1]

Canon Medical Informatics, Inc. appears as the FDA applicant, while product pages and release notes are published under Canon Medical Informatics, Canon Medical Systems Corporation and Canon Medical Systems, USA names. The global site notes that references to Canon Medical Systems Corporation refer to CANON INC. The public documents do not establish a corporate ownership structure beyond those published statements. [3][5][7][8]